Jubilant Pharmova Limited

NSEI:JUBLPHARMA Rapporto sulle azioni

Cap. di mercato: ₹185.0b

La traduzione di questa pagina è sperimentale e in fase di sviluppo. Siamo lieti di ricevere vostro !

Jubilant Pharmova Dividendo

Dividendo criteri di controllo 3/6

Jubilant Pharmova è una società che paga dividendi con un rendimento attuale di 0.55%.

Informazioni chiave

0.4%

Rendimento del dividendo

103%

Rapporto di remunerazione

Rendimento medio del settore0.6%
Prossima data di pagamento dei dividendin/a
Data di stacco del dividendon/a
Dividendo per azione₹5.000
Utile per azione₹34.91
Previsione del rendimento del dividendo0.3%

Aggiornamenti recenti sui dividendi

Jubilant Pharmova (NSE:JUBLPHARMA) Has Announced A Dividend Of ₹5.00

Aug 01
Jubilant Pharmova (NSE:JUBLPHARMA) Has Announced A Dividend Of ₹5.00

Recent updates

Jubilant Pharmova Limited (NSE:JUBLPHARMA) Surges 25% Yet Its Low P/S Is No Reason For Excitement

Aug 24
Jubilant Pharmova Limited (NSE:JUBLPHARMA) Surges 25% Yet Its Low P/S Is No Reason For Excitement

Jubilant Pharmova (NSE:JUBLPHARMA) Has A Somewhat Strained Balance Sheet

Jul 13
Jubilant Pharmova (NSE:JUBLPHARMA) Has A Somewhat Strained Balance Sheet

Jubilant Pharmova (NSE:JUBLPHARMA) Has A Somewhat Strained Balance Sheet

Mar 14
Jubilant Pharmova (NSE:JUBLPHARMA) Has A Somewhat Strained Balance Sheet

Jubilant Pharmova Limited (NSE:JUBLPHARMA) Shares Fly 27% But Investors Aren't Buying For Growth

Dec 23
Jubilant Pharmova Limited (NSE:JUBLPHARMA) Shares Fly 27% But Investors Aren't Buying For Growth

These 4 Measures Indicate That Jubilant Pharmova (NSE:JUBLPHARMA) Is Using Debt Extensively

Dec 02
These 4 Measures Indicate That Jubilant Pharmova (NSE:JUBLPHARMA) Is Using Debt Extensively

These 4 Measures Indicate That Jubilant Pharmova (NSE:JUBLPHARMA) Is Using Debt Extensively

Jul 26
These 4 Measures Indicate That Jubilant Pharmova (NSE:JUBLPHARMA) Is Using Debt Extensively

Estimating The Fair Value Of Jubilant Pharmova Limited (NSE:JUBLPHARMA)

May 11
Estimating The Fair Value Of Jubilant Pharmova Limited (NSE:JUBLPHARMA)

Is Jubilant Pharmova (NSE:JUBLPHARMA) A Risky Investment?

Dec 10
Is Jubilant Pharmova (NSE:JUBLPHARMA) A Risky Investment?

Jubilant Pharmova (NSE:JUBLPHARMA) Has Announced A Dividend Of ₹5.00

Aug 01
Jubilant Pharmova (NSE:JUBLPHARMA) Has Announced A Dividend Of ₹5.00

Does Jubilant Pharmova (NSE:JUBLPHARMA) Have A Healthy Balance Sheet?

Jun 15
Does Jubilant Pharmova (NSE:JUBLPHARMA) Have A Healthy Balance Sheet?

Calculating The Intrinsic Value Of Jubilant Pharmova Limited (NSE:JUBLPHARMA)

Mar 22
Calculating The Intrinsic Value Of Jubilant Pharmova Limited (NSE:JUBLPHARMA)

Is Jubilant Pharmova (NSE:JUBLPHARMA) A Risky Investment?

Feb 15
Is Jubilant Pharmova (NSE:JUBLPHARMA) A Risky Investment?

Calculating The Intrinsic Value Of Jubilant Pharmova Limited (NSE:JUBLPHARMA)

Dec 20
Calculating The Intrinsic Value Of Jubilant Pharmova Limited (NSE:JUBLPHARMA)

Here's Why It's Unlikely That Jubilant Pharmova Limited's (NSE:JUBLPHARMA) CEO Will See A Pay Rise This Year

Sep 15
Here's Why It's Unlikely That Jubilant Pharmova Limited's (NSE:JUBLPHARMA) CEO Will See A Pay Rise This Year

Here's Why Jubilant Pharmova (NSE:JUBLPHARMA) Can Manage Its Debt Responsibly

Aug 21
Here's Why Jubilant Pharmova (NSE:JUBLPHARMA) Can Manage Its Debt Responsibly

Time To Worry? Analysts Are Downgrading Their Jubilant Pharmova Limited (NSE:JUBLPHARMA) Outlook

Jun 08
Time To Worry? Analysts Are Downgrading Their Jubilant Pharmova Limited (NSE:JUBLPHARMA) Outlook

An Intrinsic Calculation For Jubilant Pharmova Limited (NSE:JUBLPHARMA) Suggests It's 39% Undervalued

May 25
An Intrinsic Calculation For Jubilant Pharmova Limited (NSE:JUBLPHARMA) Suggests It's 39% Undervalued

Analysts Just Made A Major Revision To Their Jubilant Pharmova Limited (NSE:JUBILANT) Revenue Forecasts

Feb 10
Analysts Just Made A Major Revision To Their Jubilant Pharmova Limited (NSE:JUBILANT) Revenue Forecasts

Estimating The Fair Value Of Jubilant Pharmova Limited (NSE:JUBILANT)

Feb 08
Estimating The Fair Value Of Jubilant Pharmova Limited (NSE:JUBILANT)

Shareholders Are Thrilled That The Jubilant Life Sciences (NSE:JUBILANT) Share Price Increased 217%

Jan 11
Shareholders Are Thrilled That The Jubilant Life Sciences (NSE:JUBILANT) Share Price Increased 217%

Does Jubilant Life Sciences' (NSE:JUBILANT) CEO Salary Compare Well With Industry Peers?

Dec 31
Does Jubilant Life Sciences' (NSE:JUBILANT) CEO Salary Compare Well With Industry Peers?

Read This Before Selling Jubilant Life Sciences Limited (NSE:JUBILANT) Shares

Dec 20
Read This Before Selling Jubilant Life Sciences Limited (NSE:JUBILANT) Shares

Has Jubilant Life Sciences Limited's (NSE:JUBILANT) Impressive Stock Performance Got Anything to Do With Its Fundamentals?

Dec 08
Has Jubilant Life Sciences Limited's (NSE:JUBILANT) Impressive Stock Performance Got Anything to Do With Its Fundamentals?

We Think Jubilant Life Sciences (NSE:JUBILANT) Can Stay On Top Of Its Debt

Nov 27
We Think Jubilant Life Sciences (NSE:JUBILANT) Can Stay On Top Of Its Debt

Stabilità e crescita dei pagamenti

Recupero dei dati sui dividendi

Dividendo stabile: I dividendi per azione di JUBLPHARMA sono rimasti stabili negli ultimi 10 anni.

Dividendo in crescita: I pagamenti dei dividendi di JUBLPHARMA sono aumentati negli ultimi 10 anni.


Rendimento dei dividendi rispetto al mercato

Jubilant Pharmova Rendimento dei dividendi rispetto al mercato
Come si colloca il rendimento da dividendo di JUBLPHARMA rispetto al mercato?
SegmentoRendimento dei dividendi
Azienda (JUBLPHARMA)0.4%
Fondo del 25% del mercato (IN)0.2%
Top 25% del mercato (IN)1.0%
Media del settore (Pharmaceuticals)0.6%
Analista previsionale (JUBLPHARMA) (fino a 3 anni)0.3%

Dividendo notevole: Il dividendo di JUBLPHARMA ( 0.55% ) è più alto rispetto al 25% inferiore dei pagatori di dividendi nel mercato Indian ( 0.25% ).

Dividendo elevato: Il dividendo di JUBLPHARMA ( 0.55% ) è basso rispetto al 25% dei maggiori pagatori di dividendi nel mercato Indian ( 1.08%.


Distribuzione degli utili agli azionisti

Copertura degli utili: Con il suo elevato payout ratio ( 102.8% ), i pagamenti dei dividendi di JUBLPHARMA non sono ben coperti dagli utili.


Pagamenti in contanti agli azionisti

Copertura del flusso di cassa: Con il suo elevato cash payout ratio ( 107.6% ), i pagamenti dei dividendi di JUBLPHARMA non sono ben coperti dai flussi di cassa.


Scoprire le società che pagano dividendi forti